Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer
Clinical trial NCT05003037 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05003037
- Sponsor
- Li Zhang, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-06
- Primary completion
- 2025-11-03
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.